These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27563647)
21. Cancer Immunotherapy for Gliomas: Overview and Future Directions. Hashimoto N Neurol Med Chir (Tokyo); 2016 Jul; 56(7):355-60. PubMed ID: 27087194 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in cancer immunotherapy with an emphasis on vaccines. Cavallo F; Forni G Expert Rev Vaccines; 2009 Jan; 8(1):25-8. PubMed ID: 19093768 [TBL] [Abstract][Full Text] [Related]
23. Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer. Shang Y; Zhou F Front Oncol; 2019; 9():917. PubMed ID: 31616632 [TBL] [Abstract][Full Text] [Related]
24. Cancer Immunotherapy: An Updated Overview of Current Strategies and Therapeutic Agents. Abu-Shawer O; Bushnaq T; Abu-Shawer M Gulf J Oncolog; 2019 Jan; 1(29):76-82. PubMed ID: 30956199 [TBL] [Abstract][Full Text] [Related]
25. [Non Hodgkin's lymphomas: a major breakthrough with immunotherapy]. Firescu R; Muylle K; Roelandts M; de Wind A; Moerman C; Lemort M; Kentos A; Meuleman N; Bron D Rev Med Brux; 2011; 32(2):83-92. PubMed ID: 21688592 [TBL] [Abstract][Full Text] [Related]
26. Overview of tumor cell-based vaccines. Copier J; Dalgleish A Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778 [TBL] [Abstract][Full Text] [Related]
27. Recent advances in applying nanotechnologies for cancer immunotherapy. Mahjub R; Jatana S; Lee SE; Qin Z; Pauli G; Soleimani M; Madadi S; Li SD J Control Release; 2018 Oct; 288():239-263. PubMed ID: 30223043 [TBL] [Abstract][Full Text] [Related]
28. Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells. Dianat-Moghadam H; Rokni M; Marofi F; Panahi Y; Yousefi M J Cell Physiol; 2018 Jan; 234(1):259-273. PubMed ID: 30144312 [TBL] [Abstract][Full Text] [Related]
29. Advances in immunotherapy for pancreatic cancer: 2013. DeVito NC; Saif MW JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925 [TBL] [Abstract][Full Text] [Related]
30. Basic Overview of Current Immunotherapy Approaches in Cancer. Velcheti V; Schalper K Am Soc Clin Oncol Educ Book; 2016; 35():298-308. PubMed ID: 27249709 [TBL] [Abstract][Full Text] [Related]
31. Immunotherapy for Melanoma. Glitza Oliva IC; Alqusairi R Adv Exp Med Biol; 2018; 995():43-63. PubMed ID: 30539505 [TBL] [Abstract][Full Text] [Related]
32. Advances in immunotherapy for colorectal cancer: a review. Golshani G; Zhang Y Therap Adv Gastroenterol; 2020; 13():1756284820917527. PubMed ID: 32536977 [TBL] [Abstract][Full Text] [Related]
33. Advances in Engineering Cells for Cancer Immunotherapy. Xu X; Li T; Shen S; Wang J; Abdou P; Gu Z; Mo R Theranostics; 2019; 9(25):7889-7905. PubMed ID: 31695806 [TBL] [Abstract][Full Text] [Related]
34. [Role of the Immune System and Possibilities of Immunotherapy in Prostate Cancer]. Kubáčková K Klin Onkol; 2015; 28 Suppl 4():4S69-72. PubMed ID: 26647892 [TBL] [Abstract][Full Text] [Related]
35. [Cancer Vaccine Focused on Neoantigens]. Shindo Y; Hazama S; Nagano H Gan To Kagaku Ryoho; 2019 Sep; 46(9):1367-1371. PubMed ID: 31530772 [TBL] [Abstract][Full Text] [Related]
36. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental? Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431 [TBL] [Abstract][Full Text] [Related]
37. Delivery strategies of cancer immunotherapy: recent advances and future perspectives. Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642 [TBL] [Abstract][Full Text] [Related]